EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180 | -1.1% | 23,120 | +4.8% | 0.00% | 0.0% |
| Q2 2023 | $182 | +18.2% | 22,064 | +4.2% | 0.00% | 0.0% |
| Q1 2023 | $154 | -17.2% | 21,183 | +1.1% | 0.00% | 0.0% |
| Q4 2022 | $186 | -99.9% | 20,961 | -6.6% | 0.00% | -50.0% |
| Q3 2022 | $275,000 | +111.5% | 22,450 | +104.4% | 0.00% | +100.0% |
| Q2 2022 | $130,000 | -51.3% | 10,983 | -21.8% | 0.00% | 0.0% |
| Q1 2022 | $267,000 | -24.1% | 14,040 | +5.8% | 0.00% | -50.0% |
| Q4 2021 | $352,000 | -19.8% | 13,269 | +24.0% | 0.00% | 0.0% |
| Q3 2021 | $439,000 | -3.9% | 10,697 | +32.7% | 0.00% | -33.3% |
| Q2 2021 | $457,000 | +59.2% | 8,063 | +17.8% | 0.00% | +50.0% |
| Q1 2021 | $287,000 | -25.8% | 6,843 | +24.1% | 0.00% | 0.0% |
| Q4 2020 | $387,000 | +56.7% | 5,514 | -20.1% | 0.00% | 0.0% |
| Q2 2018 | $247,000 | -2.4% | 6,902 | -16.2% | 0.00% | 0.0% |
| Q4 2017 | $253,000 | +954.2% | 8,240 | +725.7% | 0.00% | – |
| Q2 2016 | $24,000 | – | 998 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
| Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
| Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
| Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
| PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
| CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
| Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
| CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |